DECISION OF THE EEA JOINT COMMITTEE No 266/2023

of 27 October 2023

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/1148]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

(1) Commission Implementing Regulation (EU) 2023/1078 of 2 June 2023 approving ozone generated from oxygen as an active substance for use in biocidal products of product-types 2, 4, 5 and 11 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( 1 ) is to be incorporated into the EEA Agreement.

(2) Commission Implementing Regulation (EU) 2023/1079 of 2 June 2023 approving (13Z)-hexadec-13-en-11-yn-1-yl acetate as an active substance for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( 2 ) is to be incorporated into the EEA Agreement.

(3) Commission Implementing Decision (EU) 2023/1084 of 1 June 2023 on the unresolved objections regarding the conditions for granting an authorisation for the biocidal product A-Quasan in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( 3 ) is to be incorporated into the EEA Agreement.

(4) Commission Implementing Decision (EU) 2023/1085 of 2 June 2023 postponing the expiry date of the approval of Bacillus thuringiensis subsp. israelensis Serotype H14, Strain AM65-52 for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( 4 ) is to be incorporated into the EEA Agreement.

(5) Commission Implementing Decision (EU) 2023/1086 of 2 June 2023 postponing the expiry date of the approval of metofluthrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( 5 ) is to be incorporated into the EEA Agreement.

(6) Commission Implementing Decision (EU) 2023/1087 of 2 June 2023 postponing the expiry date of the approval of lambda-cyhalothrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( 6 ) is to be incorporated into the EEA Agreement.

(7) Commission Implementing Decision (EU) 2023/1088 of 2 June 2023 postponing the expiry date of the approval of deltamethrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( 7 ) is to be incorporated into the EEA Agreement.

(8) Commission Implementing Decision (EU) 2023/1097 of 5 June 2023 not approving cyanamide as an existing active substance for use in biocidal products of product-types 3 and 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( 8 ) is to be incorporated into the EEA Agreement.

(9) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following points are inserted after point 12zzzzzzzzzd (Commission Implementing Regulation (EU) 2023/680) of Chapter XV of Annex II to the EEA Agreement:

‘12zzzzzzzzze.

32023 R 1078 : Commission Implementing Regulation (EU) 2023/1078 of 2 June 2023 approving ozone generated from oxygen as an active substance for use in biocidal products of product-types 2, 4, 5 and 11 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 144, 5.6.2023, p. 7 ).

12zzzzzzzzzf.

32023 R 1079 : Commission Implementing Regulation (EU) 2023/1079 of 2 June 2023 approving (13Z)-hexadec-13-en-11-yn-1-yl acetate as an active substance for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 144, 5.6.2023, p. 11 ).

12zzzzzzzzzg.

32023 D 1084 : Commission Implementing Decision (EU) 2023/1084 of 1 June 2023 on the unresolved objections regarding the conditions for granting an authorisation for the biocidal product A-Quasan in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 144, 5.6.2023, p. 91 ).

12zzzzzzzzzh.

32023 D 1085 : Commission Implementing Decision (EU) 2023/1085 of 2 June 2023 postponing the expiry date of the approval of Bacillus thuringiensis subsp. israelensis Serotype H14, Strain AM65-52 for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 144, 5.6.2023, p. 94 ).

12zzzzzzzzzi.

32023 D 1086 : Commission Implementing Decision (EU) 2023/1086 of 2 June 2023 postponing the expiry date of the approval of metofluthrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 144, 5.6.2023, p. 96 ).

12zzzzzzzzzj.

32023 D 1087 : Commission Implementing Decision (EU) 2023/1087 of 2 June 2023 postponing the expiry date of the approval of lambda-cyhalothrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 144, 5.6.2023, p. 98 ).

12zzzzzzzzzk.

32023 D 1088 : Commission Implementing Decision (EU) 2023/1088 of 2 June 2023 postponing the expiry date of the approval of deltamethrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 144, 5.6.2023, p. 100 ).

12zzzzzzzzzl.

32023 D 1097 : Commission Implementing Decision (EU) 2023/1097 of 5 June 2023 not approving cyanamide as an existing active substance for use in biocidal products of product-types 3 and 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 146, 6.6.2023, p. 27 ).’

Article 2

The texts of Implementing Regulations (EU) 2023/1078 and (EU) 2023/1079 and Implementing Decisions (EU) 2023/1084, (EU) 2023/1085, (EU) 2023/1086, (EU) 2023/1087, (EU) 2023/1088 and (EU) 2023/1097 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 3

This Decision shall enter into force on 28 October 2023, provided that all the notifications under Article 103(1) of the EEA Agreement have been made ( *1 ) .

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .

Done at Brussels, 27 October 2023.

For the EEA Joint Committee

The President

Pascal SCHAFHAUSER

( 1 ) OJ L 144, 5.6.2023, p. 7 .

( 2 ) OJ L 144, 5.6.2023, p. 11 .

( 3 ) OJ L 144, 5.6.2023, p. 91 .

( 4 ) OJ L 144, 5.6.2023, p. 94 .

( 5 ) OJ L 144, 5.6.2023, p. 96 .

( 6 ) OJ L 144, 5.6.2023, p. 98 .

( 7 ) OJ L 144, 5.6.2023, p. 100 .

( 8 ) OJ L 146, 6.6.2023, p. 27 .

( *1 ) No constitutional requirements indicated.

ELI: http://data.europa.eu/eli/dec/2024/1148/oj

ISSN 1977-0677 (electronic edition)